LLY
749.85
+1.61%↑
JNJ
177.08
-0.6%↓
ABBV
210.45
+0.22%↑
UNH
348.61
+8.84%↑
NVO
54.26
-0.09%↓
LLY
749.85
+1.61%↑
JNJ
177.08
-0.6%↓
ABBV
210.45
+0.22%↑
UNH
348.61
+8.84%↑
NVO
54.26
-0.09%↓
LLY
749.85
+1.61%↑
JNJ
177.08
-0.6%↓
ABBV
210.45
+0.22%↑
UNH
348.61
+8.84%↑
NVO
54.26
-0.09%↓
LLY
749.85
+1.61%↑
JNJ
177.08
-0.6%↓
ABBV
210.45
+0.22%↑
UNH
348.61
+8.84%↑
NVO
54.26
-0.09%↓
LLY
749.85
+1.61%↑
JNJ
177.08
-0.6%↓
ABBV
210.45
+0.22%↑
UNH
348.61
+8.84%↑
NVO
54.26
-0.09%↓
24h
Praegune
Min
3.23
Max
3.58
Soovitused | Osta |
---|---|
12 kuu keskmine prognoos | +290.84% upside |
Järgmine tulemuste avaldamine | 12. nov 2025 |
---|
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
10. märts 2025, 02:12 UTC
Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY
DJ
Loe
10. märts 2025, 02:12 UTC
Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY
DJ
Loe
10. märts 2025, 02:11 UTC
Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY
DJ
Loe
10. märts 2025, 02:11 UTC
Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY
DJ
Loe
10. märts 2025, 02:10 UTC
Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY
DJ
Loe
10. märts 2025, 02:10 UTC
Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Loe
10. märts 2025, 02:06 UTC
Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT
DJ
Loe
Hinnamuutus
By TipRanks
12 kuu keskmine prognoos
Keskmine 14.5 USD 290.84%
Kõrge 17 USD
Madal 12 USD
Põhineb 2 Wall Streeti analüütiku instrumendi Fortress Biotech Inc 12 kuu hinnasihil - viimase 3 kuu andmed.
By TipRanks
Osta
2 ratings
2
Osta
0
Hoia
0
Müü
Põhineb 2 analüütiku instrumendi Fortress Biotech Inc aktsia reitingul - viimase 3 kuu andmed.
$